systems and methods for performing a focused ultrasound procedure monitored using magnetic resonance imaging (mri) is provided. An mri system uses a timing sequence for transmitting radio frequency (RF) signals and detecting magnetic resonance (MR) response signals from a patient's body in response to the RF pulse sequences. A piezoelectric transducer is driven with drive signals such that the transducer emits acoustic energy towards a target tissue region within the patient's body. Parameters of the drive signals are changed at times during the timing sequence that minimize interference with the mri system detecting MR response signals, e.g., during transmission of RF signals by the mri system.
|
18. A method for performing a procedure being monitored using magnetic resonance imaging (mri), the method comprising:
transmitting radio frequency (RF) pulse sequences over the patient's body; operating a therapeutic or diagnostic device using electrical signals to perform a therapeutic or diagnostic procedure at a target tissue region within the patient's body; detecting MR response signals generated by tissue within the patient's body in response to the RF pulse sequences while the therapeutic or diagnostic device is being operated; maintaining the electrical signals substantially constant during the detecting step, thereby substantially minimizing interference with detecting MR response signals; and determining the timing sequence of the mri system by synchronizing a clock driving the mri system with a clock controlling the electrical signals to obtain a synchronization constant relating clock speeds of the clocks; determining a delay between when the mri system is initially activated and when the mri system begins transmitting RF pulse sequences; and determining the timing sequence of the mri system by adjusting a predetermined cycle period of the mri system by the delay and the synchronization constant. 1. A method for performing a focused ultrasound procedure being monitored using a magnetic resonance imaging (mri) system, the mri system using a timing sequence for transmitting radio frequency (RF) pulse sequences and detecting magnetic resonance (MR) response signals from a patient's body in response to the RF pulse sequences, the method comprising:
driving a piezoelectric transducer with electrical drive signals such that the transducer emits acoustic energy towards a target tissue region within the patient's body while the mri system is detecting MR response signals; changing parameters of the drive signals only at one or more times during the timing sequence that minimize interference with the mri system detecting MR response signals; and determining the timing sequence of the mri system, wherein determining the timing sequence of the mri system comprises synchronizing a clock driving the mri system with a clock driving the transducer to obtain a synchronization constant relating clock speeds of the clocks; determining a delay between when the mri system is initially activated and when the mri system begins transmitting RF pulse sequences; and determining the timing sequence of the mri system by adjusting a predetermined cycle period of the mri system by the delay and the synchronization constant.
9. A system for performing a focused ultrasound procedure being monitored using a magnetic resonance imaging (mri) system, the mri system using a timing sequence to control transmitting radio frequency (RF) signals and detecting magnetic resonance (MR) response signals from a patient's body in response to the RF signals, comprising:
a piezoelectric transducer; drive circuitry coupled to the transducer, the drive circuitry configured for providing drive signals to the transducer such that the transducer emits acoustic energy towards a target tissue region within the patient's body; a controller coupled to the drive circuitry for activating the transducer simultaneously with the mri system, the controller configured for controlling the drive circuitry to change parameters of the drive signals at one or more times during the timing sequence that substantially minimize interference with the mri system detecting MR response signals generated by the patient's body; and means coupled to the controller for determining the timing sequence of the mri system, comprising means for synchronizing a clock driving the mri system with a clock driving the transducer to obtain a synchronization constant relating clock speeds of the clocks; and means for determining a delay between when the mri system is initially activated and when the mri system begins transmitting RF signals; wherein the controller is configured for determining the timing sequence of the mri system by adjusting a predetermined cycle period of the mri system by the delay and by the synchronization constant.
2. The method of
3. The method of
4. The method of
5. The method of
6. The method of
7. The method of
8. The method of
10. The system of
11. The system of
12. The system of
13. The system of
14. The system of
15. The system of
16. The system of
17. The system of
19. The method of
20. The method of
21. The method of
22. The method of
23. The method of
24. The method of
25. The method of
|
The present invention relates generally to systems and methods for minimizing interference between a magnetic imaging ("MRI") system and other electrical or electronic systems used in conjunction with an MRI system, such as focused ultrasound and/or ultrasound imaging systems, and more particularly to systems and methods for synchronizing changes in operating parameters or other electrical activities, e.g., during focused ultrasound procedures, with the timing of magnetic resonance imaging cycles.
Focused ultrasound systems have been suggested for directing heat to a target tissue region within a patient, such as a cancerous or benign tumor, to necrose or otherwise treat the tissue region with thermal energy. For example, a piezoelectric transducer located outside the patient's body may be used to focus high intensity acoustic waves, such as ultrasonic waves (acoustic waves with a frequency greater than about twenty kilohertz (20 kHz), and more typically between fifty kiloHertz and five Megahertz (0.05-5 MHz)), at an internal tissue region of a patient to therapeutically treat the tissue region. The ultrasonic waves may be used to ablate a tumor, thereby obviating the need for invasive surgery.
During such procedures, it is often desirable to image the tissues being treated, for example, using magnetic resonance imaging ("MRI"). Generally, an MRI system includes a static field magnet, a gradient field amplifier, a radio frequency ("RF") transmitter, and an RF receiver. The magnet includes a region for receiving a patient therein, and provides a static, relatively homogeneous magnetic field over the patient. A gradient field amplifier generates magnetic field gradients that vary the static magnetic field. The RF transmitter transmits RF pulse sequences over the patient to cause the patient's tissues to emit MR response signals. Raw MR response signals may be sensed by the RF receiver and then passed to a computation unit that computes an MR image, which may then be displayed.
An MRI system may be used to plan a procedure, for example, before a surgical or minimally invasive procedure, such as a focused ultrasound ablation procedure. A patient may initially be scanned in an MRI system to locate a target tissue region and/or to plan a trajectory between an entry point and the tissue region in preparation for a procedure. Once the target tissue region has been identified, MRI may be used during the procedure, for example, to image the tissue region and/or to guide the trajectory of an external ultrasound beam to a target tissue region being treated. In addition, an MRI system may be used to monitor the temperature of the tissue region during the procedure, for example, to ensure that only the target tissue region is destroyed during an ablation procedure without damaging surrounding healthy tissue.
One of the potential problems encountered when using MRI to image a focused ultrasound procedure is interference between the MRI system and the focused ultrasound system. An MRI system may be sensitive to radio frequency ("RF") signals, particularly those within the bandwidth used by the MRI system (which, for 1.5 Tesla MRI systems, generally is centered about sixty three MegaHertz (63 MHz)). In particular, transient signals, such as those used to drive a focused ultrasound system, may generate wide band noise and/or may radiate harmonics within the sensitive range of the MRI system. This noise may interfere with the MRI system, particularly when the RF receiver is activated and detecting MR response signals.
Accordingly, systems and methods for improving the results of magnetic resonance imaging during focused ultrasound procedures would be useful.
The present invention is directed generally to systems that operate in synchronization with a magnetic resonance imaging ("MRI") system, for example, during therapeutic, imaging, diagnostic, and/or other ultrasound procedures. Operation of these systems may be synchronized with operation of the MRI system to minimize interference between the systems. Preferably, systems and methods are provided for performing focused ultrasound procedures being monitored using magnetic resonance imaging, and more particularly to systems and methods for synchronizing active operations, such as changes in sonication parameters, burst transmissions, channel sampling, and the like, during focused ultrasound procedures with the timing of magnetic resonance imaging cycles to minimize interference with sensitive segments of the MRI process.
In accordance with one aspect of the present invention, a system is provided that includes an ("MRI") system, and a focused ultrasound system. The MRI system generally includes a static field magnet for generating a substantially static, homogenous magnetic field, a gradient field amplifier for varying the magnetic field in a predetermined manner, and a radio frequency ("RF") transmitter/receiver. The RF transmitter/receiver may include an RF transmitter for generating RF signals, e.g., pulse sequences, and a separate receiver for detecting MR responses of tissue. Alternatively, the RF transmitter/receiver may be a single device configured to operate alternatively in transmit and receive modes. The MRI system may include an MRI controller for providing a timing sequence or otherwise controlling operation of the RF transmitter/receiver and/or other components of the MRI system.
The focused ultrasound system ("FUS") includes a piezoelectric transducer, drive circuitry coupled to the transducer, and an FUS controller coupled to the drive circuitry. The drive circuitry is configured for providing drive signals to the transducer, which may include one or more transducer elements, such that the transducer emits acoustic energy towards a target tissue region within the patient's body.
The FUS controller is configured for controlling the drive circuitry to change parameters of the drive signals or otherwise activate the focused ultrasound system at one or more times during the timing sequence that substantially minimize interference with the MRI system detecting MR response signals generated by the patient's body. For example, the FUS controller may determine the timing sequence of the MRI system and control the drive circuitry based upon the timing sequence of the MRI system. Preferably, the FUS controller controls the drive circuitry to change parameters of the drive signals, e.g., frequency, amplitude, and/or phase, and/or perform other transient operations only when the MRI system transmits RF signals. Thus, the FUS controller may maintain the parameters of the drive signals substantially constant when the MRI system is detecting MR response signals emitted by the patient's body.
In one embodiment, an interface is provided for sampling timing signals generated by the MRI system, the timing signals being used to instruct the RF transmitter/receiver to transmit RF signals or to detect MR response signals. Preferably, the interface includes a cable for connecting to a timing sequence sampling port of the MRI system to the FUS controller. The FUS controller may change parameters of the drive signals only at one or more times during the timing sequence that minimize interference with the MRI system detecting MR response signals, as described above.
In an alternative embodiment, an antenna or other sensor may be coupled to the controller for detecting the RF signals transmitted by the MRI system. The FUS controller may use data obtained by the antenna to determine when the MRI system is beginning or terminating transmission of RF signals and/or detecting MR response signals, and control the focused ultrasound system accordingly.
In a further alternative, the FUS controller may synchronize clocks driving the MRI system and the transducer to obtain a synchronization constant relating clock speeds of the clocks. A delay between when the MRI system is initially activated and when the MRI system begins transmitting RF signals may be determined, e.g., empirically. The FUS controller may then determine the timing sequence of the MRI system by adjusting a predetermined cycle period of the MRI system by the delay and by the synchronization constant.
In accordance with another aspect, a method is provided for performing a focused ultrasound procedure being monitored using magnetic resonance imaging. Radio frequency (RF) pulse sequences are transmitted over the patient's body, e.g., using an MRI system, such as that described above. A piezoelectric transducer may be driven with electrical drive signals such that the transducer emits acoustic energy towards a target tissue region within the patient's body. MR response signals generated by tissue within the patient's body in response to the RF pulse sequences may be detected, e.g., by a receiver of the MRI system. Any activities generating signals that may interfere with the MRI receiver, e.g., by the focused ultrasound system and/or other electrical or electronic devices, may be synchronized with the MRI system, such as changing parameters of the drive signals to the transducer, sampling channels, and the like. Preferably, these "noisy" activities are performed only during the transmit phase of the MRI cycle, thereby substantially minimizing interference with detecting the MR response signals during the receive phase of the MRI cycle.
Other objects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
Preferred embodiments of the present invention are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings, in which like reference numerals refer to like components, and in which:
Turning now to the drawings,
With particular reference to
In alternative embodiments, the transducer 14 may include one or more transducer elements having a variety of geometric shapes, such as hexagons, triangles, squares, and the like, and may be disposed about a central axis 28, preferably but not necessarily, in a substantially uniform or symmetrical configuration. The configuration of the transducer 14, however, is not important to the present invention, and any of a variety of known ultrasound transducers may be used, such as flat circular arrays, linear arrays, and the like. Additional information on the construction of a phased array transducer appropriate for use with the present invention may be found, for example, in C. Cain and S. Umemura, "Concentric-Ring and Sector-Vortex Phased-Array Applicators for Ultrasound Hyperthermia," IEEE Transactions on Microwave Theory and Techniques, vol. MTT-34, no. 5, pages 542-551 (May 1986); and T. Fjield and K. Hynynen, "The Combined Concentric-Ring and Sector-Vortex Phased Array for MRI Guided Ultrasound Surgery," IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 44, no. 5, pages 1157-1167 (Sept. 1997), the disclosures of which are expressly incorporated herein by reference.
Returning to
A positioning system 34 may be connected to the transducer 14 for mechanically moving the transducer 14 in one or more directions, and preferably in any of three orthogonal directions. Alternatively, a focal distance (a distance from the transducer 14 to a focal zone 38 of the ultrasonic energy emitted by the transducer 14) may be adjusted electronically, e.g., using known methods, or using a combination of mechanical and electronic positioning. Exemplary transducers and positioning systems are disclosed in co-pending application Ser. Nos. 09/556,095, and 09/557,078, both filed Apr. 21, 2000. The disclosures of these references and any others cited therein are expressly incorporated herein by reference.
The top of the table 30 generally includes a flexible membrane 36 that is substantially transparent to ultrasound, such as mylar, polyvinyl chloride (PVC), or other suitable plastic material. A fluid-filled bag (not shown) may be provided on the membrane 36 that may conform easily to the contours of the patient 40 disposed on the table 30, thereby acoustically coupling the patient 40 to the transducer 14 within the chamber 32. In addition or alternatively, an acoustic gel, water, or other fluid (not shown) may be provided between the patient 40 and the membrane 36 to facilitate further acoustic coupling.
With particular reference to
The FUS controller 18 is coupled to the drive circuitry 16 for controlling several aspects of the drive signals 17 generated by the drive circuitry 16, such as amplitude, frequency, and/or phase. For example, the FUS controller 18 may control the amplitude of the drive signals 17 to control the intensity of ultrasonic energy delivered by the transducer 14, in a substantially conventional manner.
In addition, the FUS controller 18 may control a phase component of the drive signals 17 to respective transducer elements 22 to control a shape of a focal zone generated by the transducer 14 and/or to move the focal zone to a desired location. For example, the FUS controller 18 may control the phase shift of the drive signals based upon a radial position of respective transducer elements 22, e.g., to adjust a focal distance of the focal plane (i.e., the distance from the face of the transducer to the center of the focal zone). In addition or alternatively, the FUS controller 18 may control the positioning system 34 to move the transducer 14, and consequently the location of the focal zone 38 of the transducer 14, to a desired location, i.e., within the target tissue region 42.
Preferably, the FUS controller 18 is also configured for synchronizing and/or otherwise controlling the drive circuitry 16 and/or the transducer 14 to substantially minimize interference with the MRI system 50, as described further below.
Returning to
The RF transmitter 56 generates and transmits RF pulse sequences or other signals over the patient 40 to cause the tissue structure 42 to emit MR response signals, which may include free induction decay (FID) signals and/or echo signals. In a preferred embodiment, the RF transmitter 56 includes RF coils (not shown) in the magnet 52, and a pulse transmitter (also not shown), which may have a pulse transmitter frequency supplied by a synthesizer (not shown) and/or controlled by the MRI controller 64.
Raw MR response signals may be sensed by the receiver 58, which may include a separate set of RF coils (not shown) from the RF transmitter 50. Alternatively, an RF transmitter/receiver (not shown) may be provided that is configured to operate alternately in a transmit mode to transmit RF pulse sequences and in a receive mode to receive the MR response signals. For this alternative embodiment, the MRI controller 64 may control this operation, for example, by switching the RF coils of the RF transmitter 56 between the transmit and receive modes.
During operation, the MRI controller 64 may provide and/or otherwise control a timing sequence used to operate the MRI system 50. The MRI system 50 may be operated using a predetermined timing sequence, e.g., having a substantially constant period. The timing sequence may include one or more signals instructing the RF transmitter 56 to transmit RF pulse sequences, and/or instructing the receiver 58 to listen for MR response sequences.
Turning to
The MR response signals may be passed from the receiver 58 to the computation unit 60, which may include an analog-to-digital converter and/or an image processor (both not shown), that computes an MR image. The computation unit 60 may then display the MR images on a display 62.
The MRI system 50 may use a variety of RF pulse sequences to generate MR images. In addition or alternatively, the MRI system 50 may employ real-time temperature-sensitive pulse sequences to rapidly acquire temperature-sensitive images of the patient 40. Optionally, temperature-sensitive images may be superimposed on other medical diagnostic images (such as conventional MR images) or provided on separate displays. Preferably, both the tissue structure 42 and regions heated by the focused ultrasound system 12 may be imaged simultaneously, thereby enabling an operator to accurately position the heated region, i.e., the focal zone 38, to correspond to the target tissue region 42. Additional information on systems and methods for obtaining temperature-sensitive MR images may be found in co-pending application Ser. No. 09/696,624, filed Oct. 20, 2000, the disclosure of which is expressly incorporated herein by reference.
Returning to
To minimize interference, the FUS controller 18 may, for example, control the drive circuitry 16 in such a way that the drive circuitry 16 only changes parameters of the drive signals 17 during portions of the timing sequence that substantially minimize interference with sensitive portions of the MRI cycle. In addition or alternatively, the FUS controller 18 may only sample drive signals 17 or perform other activities during such insensitive portions of the MRI cycle.
Preferably, the FUS controller 18 controls the drive circuitry 16 to change parameters, e.g., amplitude, phase, and/or frequency, only when the RF transmitter 56 is transmitting RF pulse sequences. Because the RF pulse sequences have relatively high intensities as compared to the drive signals 17 used to drive the transducer 14, any noise generated by the drive signals 17 may be drowned out by the RF pulse sequences. Thus, even though changing frequencies and/or other parameters of the drive signals 17 may generate noise, possibly including harmonics in the bandwidth of the MRI system 50, the noise generated may not substantially affect the RF pulse sequences generated by the RF transmitter 56.
When the receiver 58 is activated, i.e., during the receive phase(s) of the MRI cycle, the parameters of the drive signals 17 may be maintained substantially constant, e.g., clean and stationary. Thus, noise generation by the focused ultrasound system 12 may be substantially reduced while the MRI system 50 detects MR response signals generated by the patient's body, thereby improving the accuracy and/or reliability of the MR images obtained.
Turning to
Similarly, as shown in
In order to synchronize the focused ultrasound system 12 to the timing sequence of the MRI system 50, the FUS controller 18 may determine the timing sequence of the MRI system 50 in order to determine when it is best to change the drive signals 17 or perform other activities, e.g., only during the transmit mode of the MRI cycle and/or during quiet times of the receive mode.
Returning to
Although the FUS controller 18 and the MRI controller 64 have been described as being separate components, it will be appreciated by one skilled in the art that the operations performed by these controllers may be performed by one or more controllers, processors, and/or other electronic components, including software or hardware components, that may be provided as parts of the focused ultrasound system 12, the MRI system 50, and/or as a separate subsystem.
Turning to
In a further alternative (not shown), a focused ultrasound system in accordance with the present invention may use an "open loop" procedure for determining the timing sequence of the MRI system. For example, with reference to
The FUS controller may determine a delay between when the MRI system 50 is initially activated and when the RF transmitter 56 begins transmitting RF pulse sequences, e.g., from empirical data provided to the FUS controller 18. Thus, the FUS controller 18 may also be used initially to activate the MRI system 50. The FUS controller 18 may then calculate the timing sequence of the MRI system 50 by adjusting a predetermined cycle period of the MRI system 50 by the delay and the synchronization constant. The calculated timing sequence may then be used to control the components of the focused ultrasound system 12 in order to minimize interference with the MRI system 50, as explained above.
It will be appreciated by those skilled in the art that the focused ultrasound systems described herein are merely exemplary of electrical or electronic systems that may be synchronized with an MRI system. For example, other therapeutic, imaging, and/or diagnostic systems and procedures, e.g., ultrasound imaging, may be used in conjunction with MRI. Further, an MRI system may be synchronized with therapeutic, imaging, and/or other systems to substantially minimize noise and/or other interference that the MRI system may cause sensitive components and/or phases of these systems.
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
Freundlich, David, Vitek, Shuki, Ezion, Avner
Patent | Priority | Assignee | Title |
10010723, | Apr 18 2013 | PROFOUND MEDICAL INC | Therapy system for depositing energy |
10058342, | Jan 12 2006 | Gynesonics, Inc | Devices and methods for treatment of tissue |
10071266, | Aug 10 2011 | The Regents of the University of Michigan | Lesion generation through bone using histotripsy therapy without aberration correction |
10092367, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
10130828, | Jun 21 2005 | INSIGHTEC, LTD | Controlled, non-linear focused ultrasound treatment |
10182862, | Feb 02 2005 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
10188462, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
10219815, | Sep 22 2005 | The Regents of the University of Michigan | Histotripsy for thrombolysis |
10293187, | Jul 03 2013 | The Regents of the University of Michigan | Histotripsy excitation sequences optimized for bubble cloud formation using shock scattering |
10321951, | Feb 27 2009 | Gynesonics, Inc. | Needle and tine deployment mechanism |
10327830, | Apr 01 2015 | MONTERIS MEDICAL CORPORATION | Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor |
10342632, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
10537751, | Apr 29 2004 | Koninklijke Philips Electronics N V | Device for positioning the energy-generating means of an assembly for the heat treatment of biological tissues |
10548678, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Method and device for effecting thermal therapy of a tissue |
10571540, | Aug 31 2011 | INSIGHTEC, LTD | Systems and methods for avoiding MRI-originated interference with concurrently used systems |
10595819, | Apr 20 2006 | Gynesonics, Inc | Ablation device with articulated imaging transducer |
10610197, | Apr 20 2006 | Gynesonics, Inc. | Ablation device with articulated imaging transducer |
10610317, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
10675113, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Automated therapy of a three-dimensional tissue region |
10772681, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energy delivery to intraparenchymal regions of the kidney |
10780298, | Aug 22 2013 | The Regents of the University of Michigan | Histotripsy using very short monopolar ultrasound pulses |
10782371, | Aug 31 2018 | X Development LLC | NMR apparatus with permanent magnets, magnetic field sensors, and magnetic coils |
10874353, | Aug 31 2011 | INSIGHTEC, LTD | Systems and methods for avoiding MRI-originated interference with concurrently used systems |
10925579, | Nov 05 2014 | OTSUKA MEDICAL DEVICES CO , LTD | Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery |
10993770, | Nov 11 2016 | Gynesonics, Inc | Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data |
11027154, | Mar 09 2010 | PROFOUND MEDICAL INC | Ultrasonic therapy applicator and method of determining position of ultrasonic transducers |
11058399, | Oct 05 2012 | The Regents of the University of Michigan | Bubble-induced color doppler feedback during histotripsy |
11096760, | Oct 12 2007 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
11096761, | Oct 12 2007 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
11112473, | Aug 31 2011 | INSIGHTEC, LTD | Systems and methods for avoiding MRI-originated interference with concurrently used systems |
11135454, | Jun 24 2015 | The Regents of the University of Michigan | Histotripsy therapy systems and methods for the treatment of brain tissue |
11154356, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Intravascular energy delivery |
11259825, | Jan 12 2006 | Gynesonics, Inc. | Devices and methods for treatment of tissue |
11364042, | Sep 22 2005 | The Regents of the University of Michigan | Histotripsy for thrombolysis |
11419668, | Feb 02 2005 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
11419682, | Nov 11 2016 | Gynesonics, Inc. | Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data |
11432900, | Jul 03 2013 | HISTOSONICS, INC | Articulating arm limiter for cavitational ultrasound therapy system |
11564735, | Feb 27 2009 | Gynesonics, Inc. | Needle and fine deployment mechanism |
11648424, | Nov 28 2018 | HistoSonics Inc. | Histotripsy systems and methods |
11672583, | Apr 01 2015 | MONTERIS MEDICAL CORPORATION | Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor |
11701134, | Sep 22 2005 | The Regents of the University of Michigan | Histotripsy for thrombolysis |
11707637, | Sep 02 2014 | UNIVERSITE DE BORDEAUX; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX | Focused ultrasound cardiac stimulation system, portable device and cardiac stimulation, and associated methods |
11813484, | Nov 28 2018 | HISTOSONICS, INC | Histotripsy systems and methods |
11813485, | Jan 28 2020 | The Regents of the University of Michigan; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | Systems and methods for histotripsy immunosensitization |
11819712, | Aug 22 2013 | The Regents of the University of Michigan | Histotripsy using very short ultrasound pulses |
11826207, | Oct 12 2007 | Gynesonics, Inc | Methods and systems for controlled deployment of needles in tissue |
11925512, | Oct 12 2007 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
11950837, | Feb 02 2005 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
11957937, | Mar 09 2010 | Profound Medical Inc. | Ultrasonic therapy applicator and method of determining position of ultrasound transducers |
11980778, | Nov 28 2018 | HistoSonics, Inc. | Histotripsy systems and methods |
11992258, | Feb 27 2009 | Gynesonics, Inc. | Needle and tine deployment mechanism |
11998266, | Oct 12 2009 | Otsuka Medical Devices Co., Ltd | Intravascular energy delivery |
7591996, | Aug 17 2005 | University of Washington | Ultrasound target vessel occlusion using microbubbles |
7595640, | Jan 16 2007 | Siemens Healthcare GmbH | Tomographic measuring system and method for conducting measurements |
7626390, | Sep 30 2003 | KONINKLIJKE PHILIPS ELECTRONICS, N V | Electroacoustic cable for magnetic resonance applications |
7771418, | Mar 09 2005 | SUNNYBROOK HEALTH SCIENCES CENTRE | Treatment of diseased tissue using controlled ultrasonic heating |
7805180, | Feb 16 2007 | Hitachi Medical Systems America, Inc. | Method of modifying MR signals using ultrasound waves |
7815571, | Apr 20 2006 | Gynesonics, Inc | Rigid delivery systems having inclined ultrasound and needle |
7874986, | Apr 20 2006 | Gynesonics, Inc | Methods and devices for visualization and ablation of tissue |
7918795, | Feb 02 2005 | Gynesonics, Inc | Method and device for uterine fibroid treatment |
8002706, | May 22 2003 | InSightec Ltd. | Acoustic beam forming in phased arrays including large numbers of transducer elements |
8016757, | Sep 30 2005 | University of Washington | Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound |
8057408, | Sep 22 2005 | The Regents of the University of Michigan | Pulsed cavitational ultrasound therapy |
8088067, | Dec 23 2002 | Insightec Ltd | Tissue aberration corrections in ultrasound therapy |
8088072, | Oct 12 2007 | Gynesonics, Inc | Methods and systems for controlled deployment of needles in tissue |
8137274, | Oct 25 1999 | OTSUKA MEDICAL DEVICES CO , LTD | Methods to deliver high intensity focused ultrasound to target regions proximate blood vessels |
8167805, | Oct 20 2005 | OTSUKA MEDICAL DEVICES CO , LTD | Systems and methods for ultrasound applicator station keeping |
8175676, | Oct 01 2007 | National Health Research Institutes | Generating gating signals for thermal therapy |
8197409, | Sep 17 1999 | University of Washington | Ultrasound guided high intensity focused ultrasound treatment of nerves |
8206299, | Dec 16 2003 | University of Washington | Image guided high intensity focused ultrasound treatment of nerves |
8206300, | Aug 25 2009 | Gynesonics, Inc | Ablation device with articulated imaging transducer |
8211017, | Dec 16 2003 | University of Washington | Image guided high intensity focused ultrasound treatment of nerves |
8229544, | May 05 2008 | National Health Research Institutes | Detecting temperature and protein denaturation during thermal therapy |
8235901, | Apr 26 2006 | Insightec Ltd | Focused ultrasound system with far field tail suppression |
8251908, | Oct 01 2007 | InSightec Ltd. | Motion compensated image-guided focused ultrasound therapy system |
8262574, | Feb 27 2009 | Gynesonics, Inc | Needle and tine deployment mechanism |
8262577, | Oct 12 2007 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
8277398, | Oct 25 1999 | OTSUKA MEDICAL DEVICES CO , LTD | Methods and devices to target vascular targets with high intensity focused ultrasound |
8295912, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Method and system to inhibit a function of a nerve traveling with an artery |
8337434, | Sep 17 1999 | University of Washington | Methods for using high intensity focused ultrasound and associated systems and devices |
8368401, | Nov 10 2009 | Insightec Ltd | Techniques for correcting measurement artifacts in magnetic resonance thermometry |
8372009, | Oct 20 2005 | OTSUKA MEDICAL DEVICES CO , LTD | System and method for treating a therapeutic site |
8374674, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Nerve treatment system |
8388535, | Oct 25 1999 | OTSUKA MEDICAL DEVICES CO , LTD | Methods and apparatus for focused ultrasound application |
8409099, | Aug 26 2004 | Insightec Ltd | Focused ultrasound system for surrounding a body tissue mass and treatment method |
8414494, | Sep 16 2005 | University of Washington | Thin-profile therapeutic ultrasound applicators |
8425424, | Nov 19 2008 | INSIGHTEC, LTD | Closed-loop clot lysis |
8469891, | Feb 17 2011 | Siemens Medical Solutions USA, Inc. | Viscoelasticity measurement using amplitude-phase modulated ultrasound wave |
8469904, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
8506485, | Apr 20 2006 | Gynesonics, Inc | Devices and methods for treatment of tissue |
8512262, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
8517962, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
8539813, | Sep 22 2009 | The Regents of the University of Michigan | Gel phantoms for testing cavitational ultrasound (histotripsy) transducers |
8548561, | Oct 01 2007 | Insightec Ltd | Motion compensated image-guided focused ultrasound therapy system |
8556834, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Flow directed heating of nervous structures |
8608672, | Nov 23 2005 | Insightec Ltd | Hierarchical switching in ultra-high density ultrasound array |
8617073, | Apr 17 2009 | Insightec - Image Guided Treatment LTD | Focusing ultrasound into the brain through the skull by utilizing both longitudinal and shear waves |
8622937, | Nov 26 1999 | OTSUKA MEDICAL DEVICES CO , LTD | Controlled high efficiency lesion formation using high intensity ultrasound |
8661873, | Oct 14 2009 | Insightec Ltd | Mapping ultrasound transducers |
8715209, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Methods and devices to modulate the autonomic nervous system with ultrasound |
8801701, | Mar 09 2005 | SUNNYBROOK HEALTH SCIENCES CENTRE | Method and apparatus for obtaining quantitative temperature measurements in prostate and other tissue undergoing thermal therapy treatment |
8852103, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
8932237, | Apr 28 2010 | INSIGHTEC, LTD | Efficient ultrasound focusing |
8979871, | Jun 27 2012 | MONTERIS MEDICAL US, INC ; MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
8986211, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
8986231, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
8989838, | Mar 09 2005 | SUNNYBROOK HEALTH SCIENCES CENTRE | System for treatment of diseased tissue using controlled ultrasonic heating |
8992447, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
9005143, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | External autonomic modulation |
9022936, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9028412, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9033884, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9049783, | Apr 13 2012 | HISTOSONICS, INC | Systems and methods for obtaining large creepage isolation on printed circuit boards |
9061131, | Aug 17 2009 | HISTOSONICS, INC | Disposable acoustic coupling medium container |
9066679, | Aug 31 2004 | University of Washington | Ultrasonic technique for assessing wall vibrations in stenosed blood vessels |
9119951, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
9119952, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Methods and devices to modulate the autonomic nervous system via the carotid body or carotid sinus |
9125642, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | External autonomic modulation |
9144694, | Aug 10 2011 | The Regents of the University of Michigan | Lesion generation through bone using histotripsy therapy without aberration correction |
9149255, | Oct 17 2011 | BFLY OPERATIONS, INC | Image-guided high intensity focused ultrasound and related apparatus and methods |
9155521, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9174065, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
9177543, | Aug 26 2009 | Insightec Ltd | Asymmetric ultrasound phased-array transducer for dynamic beam steering to ablate tissues in MRI |
9198637, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9199097, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Energetic modulation of nerves |
9211157, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Probe driver |
9220488, | Oct 20 2005 | OTSUKA MEDICAL DEVICES CO , LTD | System and method for treating a therapeutic site |
9247924, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9268014, | Oct 17 2011 | BFLY OPERATIONS, INC | Transmissive imaging and related apparatus and methods |
9268015, | Oct 17 2011 | BFLY OPERATIONS, INC | Image-guided high intensity focused ultrasound and related apparatus and methods |
9271794, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Monitoring and noise masking of thermal therapy |
9289154, | Aug 19 2009 | Insightec Ltd | Techniques for temperature measurement and corrections in long-term magnetic resonance thermometry |
9333038, | Jun 15 2000 | MONTERIS MEDICAL CORPORATION | Hyperthermia treatment and probe therefore |
9352171, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Nerve treatment system |
9357977, | Jan 12 2006 | Gynesonics, Inc | Interventional deployment and imaging system |
9358401, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Intravascular catheter to deliver unfocused energy to nerves surrounding a blood vessel |
9387042, | Jun 15 2000 | MONTERIS MEDICAL CORPORATION | Hyperthermia treatment and probe therefor |
9412357, | Oct 14 2009 | Insightec Ltd | Mapping ultrasound transducers |
9433383, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
9486170, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
9492121, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
9504484, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
9510909, | Jun 27 2012 | MONTERIS MEDICAL CORPORATION | Image-guide therapy of a tissue |
9517047, | Jan 12 2006 | Gynesonics, Inc. | Interventional deployment and imaging system |
9526923, | Aug 17 2009 | HistoSonics, Inc.; The Regents of the University of Michigan | Disposable acoustic coupling medium container |
9541621, | Nov 10 2009 | INSIGHTEC, LTD | Techniques for correcting measurement artifacts in magnetic resonance thermometry |
9566455, | Mar 09 2010 | PROFOUND MEDICAL INC | Fluid circuits for temperature control in a thermal therapy system |
9579518, | Oct 12 2009 | OTSUKA MEDICAL DEVICES CO , LTD | Nerve treatment system |
9623266, | Aug 04 2009 | Insightec Ltd | Estimation of alignment parameters in magnetic-resonance-guided ultrasound focusing |
9636133, | Apr 30 2012 | The Regents of the University of Michigan | Method of manufacturing an ultrasound system |
9642634, | Sep 22 2005 | The Regents of the University of Michigan | Pulsed cavitational ultrasound therapy |
9667889, | Apr 03 2013 | BFLY OPERATIONS, INC | Portable electronic devices with integrated imaging capabilities |
9687681, | Jan 14 2008 | PROFOUND MEDICAL INC | Therapy system with temperature control |
9700342, | Mar 18 2014 | MONTERIS MEDICAL CORPORATION | Image-guided therapy of a tissue |
9707413, | Mar 09 2010 | PROFOUND MEDICAL INC | Controllable rotating ultrasound therapy applicator |
9770607, | Mar 09 2010 | Profound Medical Inc. | Fluid circuits for temperature control in a thermal therapy system |
9808310, | Feb 02 2005 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
9852727, | Apr 28 2010 | INSIGHTEC, LTD | Multi-segment ultrasound transducers |
9901753, | Aug 26 2009 | HISTOSONICS, INC | Ultrasound lithotripsy and histotripsy for using controlled bubble cloud cavitation in fractionating urinary stones |
9931523, | Mar 09 2010 | PROFOUND MEDICAL INC | RF power controller for ultrasound therapy system |
9943708, | Aug 26 2009 | HISTOSONICS INC | Automated control of micromanipulator arm for histotripsy prostate therapy while imaging via ultrasound transducers in real time |
9981148, | Oct 22 2010 | INSIGHTEC, LTD | Adaptive active cooling during focused ultrasound treatment |
9987080, | Feb 02 2005 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
ER3205, | |||
RE43901, | Nov 28 2000 | InSightec Ltd. | Apparatus for controlling thermal dosing in a thermal treatment system |
Patent | Priority | Assignee | Title |
4554925, | Jul 07 1982 | PICKER INTERNATIONAL LIMITED, A BRITISH COMPANY | Nuclear magnetic resonance imaging method |
5307812, | Mar 26 1993 | Insightec Ltd | Heat surgery system monitored by real-time magnetic resonance profiling |
5323779, | Mar 26 1993 | Insightec Ltd | Heat surgery system monitored by real-time magnetic resonance temperature profiling |
5938600, | Dec 14 1995 | U S PHILIPS CORPORATION | Method and device for heating by means of ultrasound |
6148225, | Sep 25 1997 | Siemens Healthcare GmbH | Ultrasound therapy apparatus and method for operating same during MR monitoring |
6188923, | Sep 30 1997 | Siemens Healthcare GmbH | Method and apparatus for local heating and global monitoring of a tissue |
6419648, | Apr 21 2000 | Insightec Ltd | Systems and methods for reducing secondary hot spots in a phased array focused ultrasound system |
6501978, | Dec 30 1999 | Koninklijke Philips Electronics N V | Interleaved operation of MRI and electronic equipment |
6506171, | Jul 27 2000 | Insightec Ltd | System and methods for controlling distribution of acoustic energy around a focal point using a focused ultrasound system |
FR2649002, | |||
WO150156, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 05 2001 | EZION, AVNER | INSIGHTEC - TXSONICS LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011936 | /0290 | |
Jun 05 2001 | FREUNDLICH, DAVID | INSIGHTEC - TXSONICS LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011936 | /0290 | |
Jun 06 2001 | VITEK, SHUKI | INSIGHTEC - TXSONICS LTD | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011936 | /0290 | |
Jun 19 2001 | InSightec-TxSonics Ltd | (assignment on the face of the patent) | / | |||
Jul 12 2005 | INSIGHTEC TXSONICS LTD | Insightec - Image Guided Treatment LTD | MERGER SEE DOCUMENT FOR DETAILS | 024120 | /0685 | |
Nov 02 2005 | Insightec - Image Guided Treatment LTD | Insightec Ltd | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 024128 | /0942 | |
Aug 31 2022 | INSIGHTEC, INC | PERCEPTIVE CREDIT HOLDINGS III, LP | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 061365 | /0820 |
Date | Maintenance Fee Events |
Sep 28 2007 | ASPN: Payor Number Assigned. |
Sep 28 2007 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Sep 28 2007 | RMPN: Payer Number De-assigned. |
Sep 28 2007 | STOL: Pat Hldr no Longer Claims Small Ent Stat |
Nov 07 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Nov 02 2015 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
May 11 2007 | 4 years fee payment window open |
Nov 11 2007 | 6 months grace period start (w surcharge) |
May 11 2008 | patent expiry (for year 4) |
May 11 2010 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 11 2011 | 8 years fee payment window open |
Nov 11 2011 | 6 months grace period start (w surcharge) |
May 11 2012 | patent expiry (for year 8) |
May 11 2014 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 11 2015 | 12 years fee payment window open |
Nov 11 2015 | 6 months grace period start (w surcharge) |
May 11 2016 | patent expiry (for year 12) |
May 11 2018 | 2 years to revive unintentionally abandoned end. (for year 12) |